Joseph Truluck serves as Executive at ADIAL PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Joseph Truluck has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 23, 2023 involved receiving (via award) 157,500 shares valued at $0.
Joseph Truluck currently holds 265,139 shares of ADIAL PHARMACEUTICALS, INC. (ADIL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Truluck has been a net neutral trader of ADIL stock. They have purchased $0 and sold $0 worth of shares.
Joseph Truluck's most recent insider trade was on May 23, 2023, when they sold 157,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 31, 2018 | ADIL | $0 | Conversion | 5,927 | $N/A | Discretionary |